AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12544868 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab (20 mg before transplantation and 20 mg on day 4)
Number of subjects: 123
Study 10370315 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional nonspecific detoxication (AND) applied for prophylaxis starting from the burn shock period
Number of subjects: 176
Study 10370315 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional nonspecific detoxication (AND) applied after sepsis has begun
Number of subjects: 176
Study 10370315 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AND application)
Number of subjects: 176
Study 10370315 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 176
Study 8736467 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading doses of imipramine hydrochloride on two consecutive days
Number of subjects: 16
Study 8736467 — intervention group
Group type: COMPARATOR
Intervention: Conventional gradually escalating dose regimen of imipramine
Number of subjects: 16
Study 1421930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-containing diet (6 g lactose/kg body weight/d)
Number of subjects: 33
Study 1421930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose-containing diet
Number of subjects: 33
Study 1421930 — intervention group
Group type: COMPARATOR
Intervention: Tests of stool reducing substances and lactose breath hydrogen test (LHBT)
Number of subjects: 33
Study 3900837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceforanide
Number of subjects: 64
Study 3900837 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine ceforanide
Number of subjects: 64
Study 31028596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group with medication review by a pharmacist
Number of subjects: 0
Study 30515483 — intervention group
Group type: EXPERIMENTAL
Intervention: Endodontic retreatment (Endo group)
Number of subjects: 20
Study 30515483 — intervention group
Group type: COMPARATOR
Intervention: Implant treatment (Implant group)
Number of subjects: 20
Study 26877214 — intervention group
Group type: EXPERIMENTAL
Intervention: Anger mood condition
Number of subjects: 190
Study 26877214 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood condition
Number of subjects: 190
Study 26877214 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 190
Study 23588487 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching (6 lower-body stretches for three 30-second repetitions)
Number of subjects: 10
Study 23588487 — intervention group
Group type: COMPARATOR
Intervention: Nonstretching condition (sat still for 10 minutes)
Number of subjects: 10
Study 22452652 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation during colonoscopy
Number of subjects: 21
Study 22452652 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation during ERCP
Number of subjects: 21
Study 22452652 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation during DBE
Number of subjects: 21
Study 22452652 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation during oesophagus/stomach endoscopic submucosal dissection
Number of subjects: 21
Study 22452652 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation
Number of subjects: 21
Study 21387805 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulation (black and white checkerboard pattern reversal)
Number of subjects: 50
Study 21387805 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual stimulation
Number of subjects: 50
Study 21387805 — intervention group
Group type: COMPARATOR
Intervention: Control group (no visual stimulation)
Number of subjects: 50
Study 21387805 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 18755343 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 123
Study 18755343 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 123
Study 15948680 — intervention group
Group type: EXPERIMENTAL
Intervention: HF‐DDS graft (test)
Number of subjects: 25
Study 15948680 — intervention group
Group type: COMPARATOR
Intervention: GA (control)
Number of subjects: 25
Study 12807373 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 113
Study 12807373 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 113
Study 10551065 — intervention group
Group type: EXPERIMENTAL
Intervention: Demineralized laminar bone sheets (experimental)
Number of subjects: 7
Study 10551065 — intervention group
Group type: COMPARATOR
Intervention: GTAM membranes (control)
Number of subjects: 7
Study 8544272 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine2-receptor antagonists
Number of subjects: 63
Study 8544272 — intervention group
Group type: COMPARATOR
Intervention: Antacids
Number of subjects: 63
Study 8544272 — intervention group
Group type: COMPARATOR
Intervention: Sucralfate
Number of subjects: 63
Study 8220395 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4-g arginine/lysine supplement
Number of subjects: 7
Study 8220395 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.85-g ornithine/tyrosine supplement
Number of subjects: 7
Study 8220395 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-g BovrilR drink
Number of subjects: 7
Study 8220395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 3114333 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 10
Study 3114333 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 10
Study 29435826 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLf) application after surgery
Number of subjects: 0
Study 29435826 — intervention group
Group type: COMPARATOR
Intervention: Classical surgical treatment
Number of subjects: 0
Study 29489098 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of levosimendan started intraoperatively after induction of anesthesia, a loading dose of 6 mg/kg with subsequent injection of a dose of 0.1 μg/kg/min for 24 hours.
Number of subjects: 40
Study 29489098 — intervention group
Group type: COMPARATOR
Intervention: Bolus of levosimendan 24 μg/kg injected 15 min before aortic clamping.
Number of subjects: 40
Study 26099761 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 2.5 mg with glycopyrrolate 0.4 mg
Number of subjects: 39
Study 26099761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 24290737 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 1200 mg
Number of subjects: 52
Study 24290737 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 6000 mg
Number of subjects: 52
Study 24290737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 24290737 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg (active control)
Number of subjects: 52
Study 21453665 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D biomodel‐assisted reconstruction
Number of subjects: 20
Study 21453665 — intervention group
Group type: EXPERIMENTAL
Intervention: Freehand constructs
Number of subjects: 20
Study 21453665 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D biomodel‐assisted bending
Number of subjects: 20
Study 21453665 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 20
Study 20183654 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy‐Adolescent Skills Training (IPT‐AST)
Number of subjects: 41
Study 20183654 — intervention group
Group type: COMPARATOR
Intervention: School Counseling (SC)
Number of subjects: 41
Study 16734607 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0
Study 16734607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14765705 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-EL
Number of subjects: 8
Study 11705721 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual search analog of latent inhibition (LI)
Number of subjects: 228
Study 10401195 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AED) alone
Number of subjects: 68
Study 10401195 — intervention group
Group type: COMPARATOR
Intervention: Antitubercular therapy and albendazole (ATB + Alb) in addition to AED
Number of subjects: 68
Study 10401195 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole group (n = 60)
Number of subjects: 68
Study 7852876 — intervention group
Group type: EXPERIMENTAL
Intervention: Antheor caval filter
Number of subjects: 300
Study 2803893 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary oxygen
Number of subjects: 30
Study 2803893 — intervention group
Group type: COMPARATOR
Intervention: Room air (Control)
Number of subjects: 30
Study 1095511 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotininum (Trasylol) 200,000 KIE infusion every 6 hours during acute alcohol withdrawal
Number of subjects: 20
Study 1095511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30788869 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature ejaculation desensitisation therapy combined with 30 mg dapoxetine hydrochloride (DTCD group)
Number of subjects: 99
Study 30788869 — intervention group
Group type: COMPARATOR
Intervention: 30 mg dapoxetine hydrochloride only (DO group)
Number of subjects: 99
Study 27864616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue (1 ml of butyl‐2‐cyanoacrylate tissue glue, Glubran®)
Number of subjects: 302
Study 27864616 — intervention group
Group type: COMPARATOR
Intervention: Absorbable sutures (polyglycolic acid sutures, Dexon®)
Number of subjects: 302
Study 27864616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue
Number of subjects: 302
Study 27864616 — intervention group
Group type: COMPARATOR
Intervention: Absorbable sutures
Number of subjects: 302
Study 24755339 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with no anticoagulation
Number of subjects: 42
Study 24755339 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with unfractionated heparin
Number of subjects: 42
Study 24755339 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous hemofiltration (CVVH) with trisodium citrate
Number of subjects: 42
Study 24755339 — intervention group
Group type: COMPARATOR
Intervention: Citrate-based CVVH
Number of subjects: 42
Study 24755339 — intervention group
Group type: COMPARATOR
Intervention: All anticoagulation methods
Number of subjects: 42
Study 23041343 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal cleansing with povidone-iodine
Number of subjects: 865
Study 23041343 — intervention group
Group type: COMPARATOR
Intervention: No cleansing (control)
Number of subjects: 865
Study 20599398 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative statin use
Number of subjects: 324
Study 20599398 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin withdrawal
Number of subjects: 324
Study 20599398 — intervention group
Group type: COMPARATOR
Intervention: Preoperative statin use
Number of subjects: 324
Study 20599398 — intervention group
Group type: COMPARATOR
Intervention: Control group (no early postoperative statin use)
Number of subjects: 324
Study 18004285 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC), 2 g/day for 60 days
Number of subjects: 0
Study 18004285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15713149 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure vessel sealing system
Number of subjects: 116
Study 15713149 — intervention group
Group type: COMPARATOR
Intervention: Suture ligation
Number of subjects: 116
Study 12941675 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/d)
Number of subjects: 376
Study 12941675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 10907625 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 32
Study 10907625 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 32
Study 10907625 — intervention group
Group type: COMPARATOR
Intervention: Control (sulfonylureas only)
Number of subjects: 32
Study 2189551 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) alone
Number of subjects: 187
Study 2189551 — intervention group
Group type: EXPERIMENTAL
Intervention: Mallinson regimen (combined and sequential 5‐FU, cyclophosphamide, methotrexate, vincristine, and mitomycin C)
Number of subjects: 187
Study 2189551 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined 5‐FU, doxorubicin, and cisplatin (FAP)
Number of subjects: 187
Study 478714 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week treatment program
Number of subjects: 86
Study 478714 — intervention group
Group type: COMPARATOR
Intervention: 5-week treatment program
Number of subjects: 86
Study 31425230 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous bilateral paravertebral block (PVB)
Number of subjects: 70
Study 31425230 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 70
Study 28357966 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 86
Study 28357966 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 86
Study 28357966 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation and Relaxation therapy
Number of subjects: 86
Study 25912560 — intervention group
Group type: EXPERIMENTAL
Intervention: ASV plus guideline-directed medical therapy (GDMT)
Number of subjects: 213
Study 25912560 — intervention group
Group type: COMPARATOR
Intervention: GDMT only
Number of subjects: 213
Study 24751470 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (0.05 mg/kg/day; max: 2.5 mg/day)
Number of subjects: 92
Study 24751470 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (2 µg/day in year 1, 4 µg/day in year 2, 6/8/10 µg/day in year 3 for 4 months)
Number of subjects: 92
Study 24751470 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous puberty
Number of subjects: 92
Study 22065235 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV and Abuse Related Shame Inventory (HARSI)
Number of subjects: 271
Study 19129278 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone (SFP) 100/1,000 microg daily
Number of subjects: 99
Study 19129278 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium/fluticasone (Tio+FP) 18/1,000 microg daily
Number of subjects: 99
Study 19129278 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (Tio) 18 microg daily
Number of subjects: 99
Study 17285888 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 0
Study 17285888 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) therapy
Number of subjects: 0
Study 17285888 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (enterally or parenterally)
Number of subjects: 0
Study 17285888 — intervention group
Group type: COMPARATOR
Intervention: G-CSF
Number of subjects: 0
Study 17285888 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 0
Study 14583440 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of essential amino acids (EAA)
Number of subjects: 13
Study 11695213 — intervention group
Group type: EXPERIMENTAL
Intervention: New dentifrice formulation (Colgate Total Plus Whitening Toothpaste)
Number of subjects: 86
Study 11695213 — intervention group
Group type: COMPARATOR
Intervention: Colgate Total Toothpaste (control)
Number of subjects: 86
Study 10682134 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine/Lamivudine
Number of subjects: 1083
Study 7643045 — intervention group
Group type: EXPERIMENTAL
Intervention: Task level programming (determination of the trajectory of a hand during arm reaching in Cartesian coordinates)
Number of subjects: 0
Study 7643045 — intervention group
Group type: COMPARATOR
Intervention: Manipulator level programming (determination of the joint coordinates)
Number of subjects: 0
Study 2492741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (40 to 120 mg/day)
Number of subjects: 21
Study 2492741 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (120 to 360 mg/day)
Number of subjects: 21
Study 2492741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 6999946 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous physostigmine salicylate (2.0 mg)
Number of subjects: 7
Study 6999946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 30455077 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 × 10^6/kg predicted bodyweight MSCs
Number of subjects: 60
Study 30455077 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 28736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia-based crowns (Zircad/Zirpress)
Number of subjects: 72
Study 28736293 — intervention group
Group type: COMPARATOR
Intervention: Metal-based crowns (porcelain fused to metal)
Number of subjects: 72
Study 26243349 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy module A (4 hours per week for 8 weeks)
Number of subjects: 120
Study 26243349 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy module B (4 hours per week for 8 weeks)
Number of subjects: 120
Study 26243349 — intervention group
Group type: COMPARATOR
Intervention: Usual treatments (control group not explicitly defined in the abstract)
Number of subjects: 120
Study 25604019 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy followed by surgery (RCS group)
Number of subjects: 56
Study 25604019 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy followed by surgery (NCS group)
Number of subjects: 56
Study 22594362 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical simulation-based educational intervention (12 participants)
Number of subjects: 27
Study 22594362 — intervention group
Group type: COMPARATOR
Intervention: Current EM curriculum (15 participants)
Number of subjects: 27
Study 20818863 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression alone
Number of subjects: 1941
Study 20818863 — intervention group
Group type: COMPARATOR
Intervention: Chest compression plus rescue breathing
Number of subjects: 1941
Study 18811097 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Dycal) base
Number of subjects: 0
Study 18811097 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide‐eugenol (Kalzinol) base
Number of subjects: 0
Study 15699931 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful recanalization (n=28)
Number of subjects: 52
Study 15699931 — intervention group
Group type: COMPARATOR
Intervention: Unsuccessful recanalization (n=24)
Number of subjects: 52
Study 15699931 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful recanalization survivors
Number of subjects: 52
Study 15699931 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful recanalization nonsurvivors
Number of subjects: 52
Study 11923809 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (50 mg oral dose)
Number of subjects: 20
Study 11923809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9934939 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy (400 mg of intramuscular testosterone cypionate biweekly for 8 weeks)
Number of subjects: 112
Study 9934939 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy
Number of subjects: 112
Study 9934939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 7769069 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer
Number of subjects: 24
Study 7769069 — intervention group
Group type: COMPARATOR
Intervention: Frozen embryo transfer
Number of subjects: 24
Study 2110575 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral glucose infusion with gastric inhibitory polypeptide
Number of subjects: 7
Study 2110575 — intervention group
Group type: COMPARATOR
Intervention: IV glucose administration
Number of subjects: 7
Study 7460479 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg intramuscular ergotamine
Number of subjects: 12
Study 7460479 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg sublingual ergotamine
Number of subjects: 12
Study 7460479 — intervention group
Group type: COMPARATOR
Intervention: Sublingual placebo
Number of subjects: 12
Study 31045765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Language Therapy (CBLT)
Number of subjects: 86
Study 31045765 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 86
Study 28241723 — intervention group
Group type: EXPERIMENTAL
Intervention: Coflex
Number of subjects: 38
Study 28241723 — intervention group
Group type: COMPARATOR
Intervention: Pedicle instrumentation and interbody fusion
Number of subjects: 38
Study 25549169 — intervention group
Group type: EXPERIMENTAL
Intervention: Level-dependent mode of hearing protection (Peltor® PowerCom Plus™ and Nacre QuietPro®)
Number of subjects: 45
Study 25549169 — intervention group
Group type: COMPARATOR
Intervention: Conventional hearing protection (level-dependent mode switched off)
Number of subjects: 45
Study 24633268 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV
Number of subjects: 119
Study 24633268 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 119
Study 24633268 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV and Control
Number of subjects: 119
Study 19939874 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (6 mg)
Number of subjects: 21
Study 19939874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 19945934 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-based evidence (PBE) methodology
Number of subjects: 0
Study 19945934 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 17902519 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium YAG laser (Group A)
Number of subjects: 60
Study 17902519 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic lithoclast (Group B)
Number of subjects: 60
Study 15036672 — intervention group
Group type: EXPERIMENTAL
Intervention: End-cut needle (BioPince) with stroke lengths of 13mm, 23mm, and 33mm
Number of subjects: 86